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Abstract 
DELAY TO HOSPITAL ARRIVAL AFTER ACUTE MYOCARDIAL 
INFARCTION IN A POPULATION-BASED SAMPLE OF ELDERLY 
PERSONS. John P. Sverha, Laura V. Vaccarino, Harlan M. Krumholz. 
Section of Cardiology, Department of Internal Medicine, Yale University, 
School of Medicine, New Haven, CT. 
The purpose of this study was to determine 1) if measures of social isolation, 
cognitive function, and functional ability are associated with prolonged delay 
to hospital arrival (> 6 hours) in elderly persons with acute myocardial 
infarction (AMI) and 2) whether prolonged delay in elderly persons with 
AMI is an independent predictor of mortality. The study sample comprised 
183 persons aged 65 years or older from the New Haven cohort of the 
Established Populations for Epidemiologic Studies of the Elderly program 
who had experienced a myocardial infarction between the years 1982 and 1992 
and for whom data describing delay time from symptom onset to hospital 
arrival was available. Information describing sociodemographic factors and 
past medical history were collected at annual interviews preceeding the 
myocardial infarction. Information describing clinical presentation, 
thrombolytic use, and hospital course following AMI was collected by chart 
review. The relationship between prolonged delay and social isolation, 
cognitive ability, and functional ability was examined by univariate and 
multivariate analysis. The effect of prolonged delay time on inhospita! 
complications, 30-day mortality, and 1-year mortality was examined by 
univariate analysis and also by multivariate analysis while controlling for 
usual predictors of mortality after AMI. Prolonged delay was found to be 

independently associated with lower Killip class, older age, absence of home 
visitation by a health care worker, and lower educational level (pc.05). 
Prolonged delay was also found to be associated with significantly elevated 30- 
day (16% vs. 29%) and 1-year mortality (35% vs. 50%) in both univariate and 
multivariate analyses. The principal finding of this study is that measures of 
social isolation, cognitive function, and functional ability were unable to 
predict prolonged delay in elderly persons with AMI. An additional finding 
is that delay time was an independent predictor of mortality in elderly 
persons with AMI. 
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1 
Introduction 
1.25 million Americans suffer a heart attack each year, of whom 
approximately 500,000 die as a result (1). Death from acute myocardial infarction 
(AMI) is the single most common way to die in America today, causing about 
one-fourth of all deaths each year (2). 
The prevalence of death due to AMI is disheartening considering the progress 
which has been made in the management of myocardial infarction. While 
bedrest was the standard of care for AMI as recently as the 1950's, it is now 
possible to correct arrythmias, limit infarct size, and even reperfuse the 
myocardium. As efforts continue to develop novel treatments for AMI, 
increasing attention is now being directed toward ways to maximize the benefits 
of current interventions. An important means of improving the effectiveness of 
today's therapies is by decreasing the time interval from the onset of symptoms 
to their administration. This understanding has prompted efforts to quantify the 
benefits of early treatment and to explain why delay to treatment occurs. 
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Benefit of Early Treatment After Acute Myocardial Infarction 
The potential benefit of early treatment after AMI is great as it is soon after 
myocardial infarction that much of the mortality occurs. In a careful study 
conducted in 1967 by Armstrong et al., it was found that 51% of deaths caused by 
AMI occured within the first 2 hours and that 74% of deaths occured within the 
first 24 hours (4). Similar results have been reported by other authors (5,6,7). 
Modem cardiac care, if delivered promptly, can prevent many of the deaths 
which occur soon after AMI. Perhaps the most important intervention to have 
available early after AMI is defibrillation. The significance of defibrillation lies in 
the fact that it is an excellent means of treating the most common cause of death 
early after AMI, ventricular fibrillation (8). It is estimated that 85% of ventricular 
fibrillation is corrected by a single countershock of 200J (9). However, prognosis 
following defibrillation is very dependent on the rapidity with which the 
countershock is administered. In a study conducted by Weaver et al. which 
followed the outcomes of 942 patients who were resuscitated after out of hospital 
ventricular fibrillation, 37% of patients survived to be discharged when 
defibrillation occurred within three minutes of ventricular fibrillation compared 
to 14% if defibrillation occurred after ten minutes (10). 
Seeking medical attention after symptoms of AMI develop allows prompt 
defibrillation if ventricular fibrillation does occur. This care should be sought 
immediately as it is soon after AMI that most episodes of ventricular fibrillation 
occur. In a study Pantridge et al. of 294 patients with AMI, 55 patients were seen 
to develop ventricular fibrillation within 12 hours of AMI. 41 of these patients 
(75%) developed ventricular fibrillation within the first two hours (11). 
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Other therapies which have been shown to improve outcome if applied early 
after AMI include nitroglycerin, beta-blockers, and aspirin. Precisely how early 
after myocardial infarction these medications must be given for maximal benefit 
is not clear. However, the pooled results of six studies of nitroglycerin in which 
it was given on hospital arrival to persons with AMI and chest pain showed an 
average mortality reduction of 33% (12). Other studies have shown beta-blocker 
therapy to reduce one-week mortality by 13% if started within 12 hours of 
hospital arrival (13) and aspirin therapy to reduce 5-week mortality by 23% if 
given within 24 hours of hospital arrival (14). 
Thrombolytic therapy is the intervention most often cited today as the chief 
reason to seek prompt medical attention after AMI. It has consistently been 
shown that the benefits of thrombolytic therapy are dependent on how soon it is 
administered after AMI. A recent meta-analysis of the nine largest randomised 
clinical trials of thrombolytic therapy shows a linear decrease in the reduction of 
35-day mortality after AMI with delay time to thrombolytic administration. The 
mean mortality reduction was 27% if thrombolytics were given within the first 
hour, 16% if given within four to six hours, and a statistically insignificant 5% if 
given in 13-24 hours (17). The current guidelines issued by the American 
College of Cardiology and the American Heart Association recommend that 
thrombolytics should generally not be given more than 6 hours after myocardial 
infarction (18). It is thought that by this time the benefits of thrombolysis have 
dwindled such that they are outweighed by the medication's side effects. 
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Delay After Acute Myocardial Infarction 
Research aimed at determining the time from symptom onset to hospital 
arrival began in the late 1960's. This initial interest in length of delay paralleled 
the development of defibrillation, the use of mobile intensive care units, and a 
growing realization that early care after AMI could save lives. A second surge of 
interest in delay time began in the late 1980's with the advent of thrombolytic 
therapy and has continued into the present. 
Length of Delay 
The median delay time reported in most studies is in the range of 2-3 hours, 
although median delay times of up to 6.5 hours have been reported (19-42)(Table 
1). Mean delay time is longer than median delay time in all studies with no 
study reporting a mean delay time of less than 4 hours. The difference between 
median and mean delay times is due to the skewing effect caused by the few 
individuals who wait many hours or even days before seeking medical care for 
their AMI. When delay time is presented in an alternative manner, the 
percentage of patients delaying >6 hours has been found to be between 21 % and 
37% (47,48). 
Variability in the delay times reported by previous authors can be partly 
explained by differences in the populations studied and differences in their 
inclusion criteria. As seen in table 1, study populations differed widely 
according to age, gender, and race. In addition, some studies granted eligibility 
to those with suspected AMI while other studies were confined to those with 
verified AMI. 
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Phases of Delay 
Delay time has typically been defined as the amount of time between an 
individual's first awareness of symptoms and arrival of the individual at the 
hospital. Given the emergence of new therapies for AMI, it is now more 
appropriate to speak of total delay time which is the interval from the onset of 
symptoms to the initiation of definitive therapy, such as thrombolytics. 
Total delay time can be understood as being composed of three separate 
phases: patient decision time, prehospital time, and hospital time. The patient 
decision time encompasses the interval from when the patient first begins to 
experience symptoms until the patient decides to go to the hospital. The 
prehospital time is defined as the amount of time between the activation of the 
emergency response system (i.e. dialing 911) and arrival at the hospital or, 
alternatively, the amount of time it takes for the patient himself to travel to the 
hospital. The hospital time encompasses the interval between arriving at the 
hospital and the initiation of definitive care. 
Research into the respective contribution of each of the three phases to total 
delay time has consistently shown that patient decision time is the most 
significant cause of delay. Direct estimates of its contribution to total delay time 
range from 50-65% (25,28,42). This correlates well with the fact that mean delay 
times are greater than 4 hours while prehospital time averages 7-22 minutes 
(32,36,42) and hospital time averages 60-90 minutes (49,50). 
Variables Affecting Total Delay Time 
The extent to which total delay time is determined by the patient decision 
phase is reflected in the variables which have been associated with total delay 

time. The following is a summary of how various variables affect total delay 
time as reported in the literature. 
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Sociodemographic Variables (Table 2) 
Age - Older age is probably correlated with increased delay time. A total of 16 
studies have examined the relationship between age and delay with 8 of the 
studies showing age to prolong delay. The remaining 8 studies demonstrated no 
correlation between age and delay. The study with the largest sample size (3,256 
participants, 1823 >65 years old) was conducted by Weaver et al. using registry 
data from Seattle, WA and showed that while median delay times did not 
increase with age, mean delay times rose form 4.1 hours to 6.1 hours (24). A 
more recent study by Yarzebski et al. involving 1279 patients showed that 
patients older than 75 were significantly more likely to delay >2 hours than 
younger patients (21). Median delay times were found to vary with age in a 
study by Turi et al. in 1986 which utilized data from the Multicenter 
Investigation of Limitation of Infarct Size (MILIS) trial (34). In this study, 
patients <55 years old presented at 2.7 hours compared with 3.3 hours for those 
over the age of 55. The largest study to conclude that age has no effect on delay 
times was conducted by Alonzo (35). However, Alonzo examined the effect of 
age on several individual phases of total delay time, making it difficult to 
compare his results with those of other studies. 
Gender - Gender has been shown to have no effect on delay times in 10 of the 
14 studies in which it was examined. In the four studies which showed a 
significant relationship between gender and delay time, female gender was 
associated with a slight increase in delay (25,34,35,43). For example, Turi et al. 
reported a median delay of 3.2 hours for women compared to 3.0 hours in men 
(34). 
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Race - Most delay time research has been conducted on populations that are 
entirely Caucasian or have contained such a small percentage of minority 
patients as to make their results difficult to interpret. There have been 2 studies, 
however, which have been conducted exclusively with black patients. The first 
study, performed by Cooper et al., involved 111 patients admitted to a municipal 
hospital in Chicago. These patients showed a remarkably long median delay 
time of over 6 hours (33). A more recent study by Ell et al. involving 448 black 
patients in Los Angeles found a median delay of 2.65 hours, which is similar to 
that seen in Caucasian populations (20). 
Education - Level of formal education acheived was not associated with delay 
time in 5 of the 6 studies in which it was examined (20,32,38,40,43). In the single 
study in which an effect was noted, low educational level was found to increase 
delay time (42). 
Socioeconomic status - Most studies have concluded that socioeconomic status 
does not effect delay time (20,32,38). An exception is a study conducted by 
Schmidt et al. which found low income one of several variables associated with 
prolonged delay in a multivariate analysis (25). 
Past Medical History (Table 3) 
Many patients who present with symptoms of AMI have a past medical 
history which includes angina, diabetes, hypertension, congestive heart failure, 
or even previous MI. It is often assumed that patients with these risk factors 
would be less likely to delay in seeking care due to their presumed familiarity 
with the medical system and the symptoms of myocardial infarction. A striking 
finding which persists across virtually all studies is that past medical history, 
even the history of a previous MI, does not affect delay time. Some authors have 
suggested that prior experience with the symptoms of AMI causes patients to be 
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less alarmed by their presence and results in a greater willingness to delay 
seeking care in the hope that symptoms will resolve. The few studies which have 
found an association between past medical history and delay time suggest that a 
history of diabetes or chronic angina may prolong delay time slightly 
(21.25.34.40) . 
Circumstances of Myocardial Infarction (Table 4) 
Several authors have investigated the effect of the timing of the myocardial 
infarction and the location of the patient when the myocardial infarction occured. 
Most authors have found that being alone at the time of AMI reduces delay time, 
perhaps because consultation with others tends to prolong delay (41,42,44). 
Studies examining the time of day the AMI occurred, whether it occurred on a 
weekend, or whether the patient was at home at the time of the MI have 
produced inconsistent results (21,32,40,42). 
Symptoms of Myocardial Infarction (Table 5) 
Several studies of delay time have recorded the frequency with which AMI 
was accompanied by chest pain with the results ranging from 64 to 91 % 
(25.29.40) . It has been suggested that atypical presentations of myocardial 
infarction (i.e. without chest pain) and the resulting confusion as to the cause of 
the pain may cause some persons to delay in seeking medical attention. 
However, no relationship between the prevalence of chest pain and delay time 
has been found in any study to date. The severity of chest pain has been linked to 
shortened delay times in the three studies in which it was examined (20,25,41). 
In the single study which examined the rate of symptom progression, it was 
found that a slow progression of symptoms was associated with longer delay 
(25). 
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Severity of Myocardial Infarction (Table 6) 
Hemodynamic instability has been shown to shorten delay time in all studies 
in which it has been examined (23,29,34). Typically, this has been measured as 
either a low presenting systolic blood pressure or a higher Killip class. The size 
of infarct as reflected by peak creatine phosphate kinase enzyme level has been 
been examined in two studies, with that by Schmidt et al. showing decreased 
delay with larger infarct size (25,28). The distinction between Q wave and non-Q 
wave MI has generally not been helpful in predicting delay except in the study 
by Turi et al. in which Q wave MI was associated with a slight decrease in 
median delay time from 3.3 to 3.0 hours (34). 
Medical Sophistication (Table 7) 
The understanding that one's symptoms are cardiac in nature has been 
associated with shorter delay times in three of four studies (22,25,26,41). 
Knowledge of thrombolytic therapy and the benefits of early treatment were 
associated with decreased delay in one of two studies (22,25). 
There have been several studies which have examined the effectiveness of 
mass education campaigns designed to reduce patient delay time after AMI. The 
results of the first investigation of this kind were published by Mitic et al. in 1984 
(46). In this study, a population of 300,000 in Nova Scotia was exposed to an 
eight week campaign utilizing TV, radio, and newspaper messages to describe 
the symptoms of AMI and the importance of early treatment. As a consequence 
of this campaign, the percentage of patients presenting in <2 hours rose 
significantly, from 15.8% to 29.3%. 
More recent studies of the effectiveness of mass education efforts have been 
less encouraging. A media campaign similar to that in Nova Scotia was 
I 
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conducted in Seattle, WA in 1986 (27). In this case, delay time was not 
significantly reduced. In addition, the proportion of persons who presented to 
the emergency department with chest pain who were confirmed to have a 
myocardial infarction decreased from 34% to 25%. The authors warned of an 
increase in emergency department visits for non-cardiac chest pain and stable 
angina as a possible drawback of future mass education campaigns. 
The most recent educational campaign aimed at reducing delay time was 
conducted in Goteburg, Sweden in 1987. Blohm et al. report that although 
median delay times were successfully reduced from 3.0 to 2.3 hours with no 
decrease in the percentage of confirmed AMI's, the mortality rate for patients 
presenting with AMI was not affected (45). 
Patient Actions After Onset of Symptoms (Table 8) 
Alonzo has reported that 93% of persons contact someone before proceeding 
to the hospital with AMI and that consulting a family member is most likely to 
prolong delay. He suggests this may be due to a shared motivation on the part of 
the family member to deny the seriousness of the event (44). Other authors have 
noted that contacting one's physician leads to increased delay time 
(22,25,28,32,44). This is thought to be due to both the frequent difficulty in 
actually contacting the physician and the occasional advice on the part of the 
physician to continue to observe the symptoms without going to the hospital. 
Still other authors have reported that self-medication after onset of symptoms is 
strongly related to prolonged delay (20,34,36,38,44). 
Coping Mechanism 
The means by which one copes with a sudden change of health status surely 
affects the length of decision time after AMI. Several authors have investigated 
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the influence of denial on delay times and have found no effect (25,32,41). 
However, these studies are hampered by the methodological problems of 
assessing denial retrospectively and the absence of an appropriate psychometric 
instrument (51). 
Developing a Model of Patient Decision-Making After AMI 
The decision to seek care after AMI is obviously complex and seems to be 
affected by a diversity of factors including sociodemographic variables, the 
nature of the symptoms, the interpretation of the symptoms by the patient, and 
consultation with others. In order to better understand why persons seek care 
after AMI, the National Heart Attack Alert Program Coordinating Committee 
has proposed a model of patient-decision making during AMI. In developing 
this model, the committee drew upon two existing decision-making models used 
in patient compliance research: the health belief model and the symbolic 
interactionism model. The focus of the health belief model is an individual's 
cognitive response to a perceived health threat and the resulting cost-benefit 
analysis of possible responses to this information. The symbolic interactionism 
model emphasizes the importance of social interactions in making health-related 
decisions. It also acknowledges that an individual's personality (or "self- 
concept") effects the process. Below is a diagram of the proposed "integrated" 
model of patient decision-making after AMI (Figure 1). 
The value of this model is in providing a hypothesis as to how the multiple 
factors shown known to influence patient delay time may interact. While it is 
important to know whether sociodemographic factors, past medical history, or 
clinical presentation are associated with delay time, it is even more useful to 
understand why or how these variables affect delay. It is only with this 
knowledge that logical interventions to reduce delay can be designed. 

Figure 1. An Integrated Model of Patient Decision-Making After AMI 
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Effect of Delay Time on Prognosis After AMI 
While the impact of delay time on mortality has been well established for 
persons who receive thrombolytics after AMI, the relationship between delay 
time and prognosis in populations in which only a fraction of persons receive 
thrombolytics is less dear. Several studies of the effect of delay time on 
prognosis conducted before the advent of thrombolysis have found increased 
mortality in those patients with longer delay times (34,33,40), although other 
authors have conduded that delay time has no effect on mortality (38,21,60,61) 
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The inconsistent effect of delay time on prognosis when thrombolytics are 
only occasionally used can be explained by the fact that delay time is influenced 
by many of the same factors that affect survival after AMI. Hemodynamic 
instability after AMI and size of infarct are both indicators of poor prognosis yet 
are strongly associated with shorter delay times (34,23,29,28). Older age, female 
gender, black race, and diabetes are also predictors of poor prognosis after AMI, 
yet have been associated with longer delay times (24,34,40,29,25,31,35,20,21). 
Any effort to determine the true effect of delay time on prognosis after AMI in 
the absence of thrombolysis must control for as many of the covariables 
described above as possible. To our knowledge, there have been only 4 previous 
studies which have attempted multivariate analyses (59,23,29,34) (Table 9). 
Three of these studies found no significant independent effect of delay time on 
prognosis although the studies conducted by Turi et al. and Cragg et al. did not 
control for the level of hemodynamic instability after myocardial infarction 
(59,34). One study, conducted by Logue et al., did find that delay time affected 
prognosis. He reported that persons who arrived in <1.5 hours experience 
increased inhospital mortality (23). 
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Purpose of Study 
Among the many factors which affect delay time after AMI, the association 
between older age and prolonged delay is particularly important. The finding 
that the elderly delay longer after AMI than younger persons is concerning for 
several reasons including: 
1) The elderly represent an expanding segment of the population. Persons aged 
65 or older currently number over 30 million in the United States and are 
expected to increase by 6 million over the next decade. This age group is 
the fastest growing segment of the population and is expected to 
comprise greater than 20% of the entire population by the year 2030 (52). 
2) The elderly are at a higher risk for AMI than younger persons. Current 
estimates are that 60% of the hospitalizations for AMI are in persons 
older than 65 (53). 
3) Increasingly aggressive early treatment of AMI is now being recommended for 
the elderly. Recent appreciation of the particularly poor prognosis of 
elderly who are not offered aggressive therapy has resulted in a 
reevaluation of conservative treatment strategies (54). This is best 
exemplified by the debate regarding the use of thrombolytic therapy in 
the elderly. Consensus is now emerging that thrombolytic therapy 
should not be denied to any patient on the basis of age alone (48). 
The reasons why the elderly are more likely than younger persons to delay 
after AMI are not clear. An understanding as to why the elderly are particularly 
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prone to delay would be helpful in identifying elderly who are at especially high 
risk for delay and for designing interventions to reduce delay in this population. 
Study Hypotheses 
This study tests the hypothesis that prolonged delay in elderly persons with 
AMI can partly be explained by increased social isolation, cognitive impairment, 
and functional disability in this population. Social isolation may cause elderly 
persons to be more hesitant in contacting others for help. Cognitive impairment 
may make it difficult to recognize the cause of one's symptoms or the neccessity 
of seeking help. Functional disability may physically prevent a person from 
seeking help. Each of these variables is unique to this study, having never been 
examined in previous studies of patient delay after AMI. 
An additional hypothesis is that prolonged delay to hospital arrival is an 
independent predictor of mortality in elderly persons with AMI. Previous 
studies examining the effect of delay time on prognosis have produced 
inconsistent results as they have often failed to control for usual predictors of 
mortality after AMI. 
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Methods 
Study design 
The study sample comprised patients from the New Haven cohort of the 
Established Populations for the Epidemiologic Study of the Elderly (EPESE) 
program. This program was initiated in 1980 by the National Institute of Aging 
with the goal of studying risk factors for chronic disease and disability in the 
elderly. The program consists of four epidemiologic cohort studies in four 
separate locations: New Haven, CT; East Boston, MA; Washington and Iowa 
Counties, Iowa; and Durham, NC. 
The New Haven cohort of EPESE, known as the Yale Health and Aging Project 
(YHAP), was established in 1982 as a longitudinal, community-based cohort 
study of 2,812 persons aged 65 years or older living in New Haven. The sample 
was stratified by housing type so that the cohort consisted of 26% who lived in 
public housing for the elderly, 31% who lived in private housing for the elderly, 
and 43% who lived in private houses or apartments. The population was 
oversampled for men so that the cohort would have equal numbers of men and 
women. The cohort is heterogeneous regarding ethnic, racial, and social 
backgrounds (58). 
Since assembling the cohort, participants have been interviewed yearly 
regarding their health status, medication use, and functional status. The initial 
contact in 1982 as well as recontacts in 1985 and 1988 were conducted by face-to- 
face interview. All other annual contacts were made by telephone interview. 
Information regarding hospitalizations and deaths came from the annual 
interviews with additional surveillance provided by obituary notices, hospital 
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records, proxy information, and the National Death Clearance. To date, less than 
one percent of the cohort has been lost to follow-up. 
The subjects in this study represent persons from the New Haven cohort of 
EPESE who were hospitalized for myocardial infarction between the years 1982 
to 1992. These patients were identified by weekly monitoring of two New Haven 
hospitals (Yale-New Haven Hospital and The Hospital of St. Raphael's) where it 
had previously been determined that 90-95% of YHAP participants were 
hospitalized for AMI. The medical records were requested for those participants 
who had a discharge diagnosis of AMI (ICD-9-CM codes 410.0-410.9) or unstable 
angina (ICD-9-CM codes 411.1 and 411.8). Patients were eligible for our study 
only if a myocardial infarction was verified to have occurred within 48 hours of 
admission and was clearly not triggered by surgery or trauma. Two of the 
following three criteria had to be present for AMI to be confirmed: 
1) Central anterior chest pain lasting at least 15 minutes or acute pulmonary 
edema or cardiogenic shock 
2) Pathological q waves (>.04 seconds) or ST elevation followed by T wave 
inversion in at least two leads 
3) Serum creatine phosphate kinase MB fraction (CPK-MB) increased to 
greater than 4% 
A total of 229 YHAP participants were confirmed by the criteria above to 
have had a myocardial infarction. Data describing the delay to hospital arrival 
was available for 183 of these 229 patients. The inpatient charts of the 183 
patients were reviewed and information describing clinical presentation, 
thrombolytic use, and inhospital complications was abstracted with the aid of a 
form designed for this purpose. 
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Definition of Delay Time 
Delay time in this study was defined as the time interval between symptom 
onset and arrival at the hospital. Delay times were classified as being less than or 
greater than six hours. This time interval was chosen as it is the most often cited 
time restriction for the use of thrombolytic therapy. 
Description of Delay Time Variables 
A description of delay time variables is provided below. For those variables 
which were assessed at more than one interview, the data collected at the most 
recent interview preceding the myocardial infarction was used. 
Sociodemographic variables 
Age - Age was measured at the time of hospitalization for myocardial infarction. 
Patients were classified into two groups based on whether they were 
between the ages of 65 and 74 or 75 years and older. 
Race - Race was assessed by asking the study participants which group described 
their racial background. The race variable was analyzed as either black or 
non-black. 
Education - The number of years of regular school completed was recorded as 
being greater than or less than 12 years. 
Medical History Variables 
Previous myocardial infarction - A previous myocardial infarction was considered 
to have occurred if it was recorded in the patient's past medical history 
when admitted for AMI. Presence of old Q waves on the admission ECG 
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without a history of infarction was not considered sufficient to qualify for 
prior infarction. 
Chronic angina pectoris - This was considered to be present when a history of 
stable angina was recorded in the admission note for AMI. Recent onset 
angina (i.e. less than one week prior to admission for AMI) was not 
considered to be chronic angina pectoris. 
Hypertension - Subjects were considered to have hypertension if either a history of 
high blood pressure was recorded on admission for AMI or, according to 
the YHAP interview preceding admission, the patient was taking 
medications for high blood pressure. 
Diabetes mellitus - A patient was classified as having diabetes mellitus if history of 
diabetes was recorded in the admission note for AMI or if the patient was 
taking insulin or oral hypoglycemic medications prior to AMI. 
Previous congestive heart failure - A history of congestive heart failure was 
recorded if such a diagnosis was stated in the admission note for AMI, or if 
the patient was taking digitalis before admission in the absence of a history 
of atrial fibrillation. 
Smoking - A distinction was made between current smokers at the time of AMI 
and those who had smoked in the past. Only the influence of current 
smoking on delay time was examined. 
Body mass index - The weight and height values reported by the participants at the 
YHAP interview preceding the myocardial infarction were used to compute 
the body mass index according to the following formula: body mass index 
= weight(kg) / height(m)2. For our analysis, body mass index was divided 
into three categories: <23 (underweight), 24-28 (acceptable or overweight), 
and 29+ (obese). 
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Previous cerebrovascular accident - This information was derived from the 
admission note at the time of myocardial infarction. 
Clinical Presentation Variables 
Systolic blood pressure - This was measured during the admission exam for AMI 
with the patients being divided into tertiles on the basis of its magnitude. 
Killip class - Hemodynamic status after myocardial infarction was measured 
according to the traditional Killip classification described below: 
I - no failure 
II - heart failure; defined by the presence of rales in the inferior half of the 
pulmonary fields in the admission exam or moderate pulmonary edema 
on chest X-ray 
III - frank pulmonary edema; defined by rales beyond the inferior half of 
the pulmonary fields or full pulmonary edema on chest X-ray 
IV - cardiogenic shock; defined by systolic blood pressure <90 on 
admission 
Presence of chest pain - Presence of chest pain during the admission exam for AMI 
or immediately prior to admission was noted. 
Peak CPK greater than four times the uppermost limit of normal- This criteria was 
used to identify particularly large infarcts. 
Conduction disorder on admission - A conduction disorder was diagnosed in the 
presence of either left bundle branch block or atrio-ventricular block (either 
second degree Mobitz type II or third degree) in any of the first three 
electrocardiograms within 48 hours of admission. 
Atrial fibrillation on admission - The presence of atrial fibrillation in any 
electrocardiogram performed within 48 hours of admission was noted. 
Type of myocardial infarction - Three categories were considered: 
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1) Q wave MI - new pathologic Q waves (>.04 seconds) on the ECG 
accompanied by either typical chest pain or CPK-MB >4% 
2) non-Q wave MI - CPK-MB >4% accompanied by either typical chest pain 
or ST-segment changes without the development of pathologic Q waves 
3) indeterminate - typical chest pain or CPK-MB elevations in the presence 
of left bundle branch block, paced rhythm, or other conditions which 
make the interpretation of Q waves difficult 
Social Isolation Variables 
Social ties - A summary measure of social ties was constructed to indicate the 
number of four different categories of ties: 
1) presence of a spouse 
2) reported contact with two or more close friends and/or relatives 
3) regular church attendance (at least once per month) 
4) membership in other types of groups 
Scores from this summary measure were determined by counting the 
number of different categories of social ties present (0,1,2,3+.) 
Living alone - Participants were asked how many persons resided in their 
household at each annual interview. 
Cognitive Function Variables 
Cognitive function - A series of seven questions testing orientation, memory, and 
concentration were asked during face-to-face interviews. A person was 
considered cognitively impaired for the purposes of this study if they 
answered three or more of these questions incorrectly. 
Dementia - A history of dementia was recorded only if it was described in the 
admission note for AMI. 
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Functional Ability Variables 
Functional disability- This variable was measured by a series of six questions in 
which participants were asked at the time of the interview whether they 
needed help walking, bathing, dressing, eating, rising from a chair, or using 
the toilet. Participants were grouped into three categories based on whether 
they where unable to independently perform zero, one, or two or more of 
the activities of daily living listed above. 
Home care worker visitation - Participants were asked if any health care worker 
visited their home on a regular basis to help take care of them. 
Description of Outcome Measures 
The outcome measures in this study included inhospital complications, 30-day 
mortality, and one-year mortality. The inhospital complications examined were 
recurrent chest pain, recurrent ischemia, reinfarction, and congestive heart failure 
after admission. They were defined as follows: 
Recurrent chest pain- Any episode of typical anterior chest pain which occurred 
after the original episode of chest pain and was not accompanied by ECG 
modifications indicative of ischemia or CPK-MB elevations above the 
normal limit. 
Recurrent ischemia- ECG modifications indicative of new ischemia which occured 
more than 48 hours after admission and were not accompanied by CPK-MB 
elevations. 
Reinfarction - Defined by the same criteria as the initial myocardial infarction 
although this myocardial infarction was required to have occurred at least 
48 hours after admission. 
I 
I 
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Congestive heart failure after admission - Determined by increased rales on 
auscultation, new S3 gallup, or chest X-ray modifications compared with the 
admission exam or chest X-ray. 
Statistical Analysis 
To determine if early (<6 hours) and late (>6 hours) arrival groups differed 
significantly regarding sociodemographic factors, past medical history, or clinical 
presentation, a univariate analysis was performed. The chi-square test was used 
for categorical variables and the Mantel-Haenszel chi-square test was used for 
interval-scaled variables. The only variable with data missing from more than 
five patients was chronic angina in which data was missing from 9 patients. 
A multivariate logistic regression analysis was then performed in an effort to 
determine which of the delay variables was significantly related to prolonged 
delay independent of the others. The variables chosen for the multivariate 
analysis are displayed in Table 11 and represent variables associated with delay 
in previous studies, variables which showed a p-value of <.20 in the univariate 
analysis, and the social isolation, cognitive impairment, and functional disability 
variables which are unique to our study. 
To determine if there was a significant relationship between prolonged delay 
and outcome, a univariate analysis using the chi-square test was performed. A 
multivariate analysis using the proportional hazards model was also conducted 
to determine if prolonged delay was associated with increased 30-day and 1-year 
mortality when controlling for other usual predictors of mortality after MI such 
as age, sex, Killip class, type of MI, and systolic blood pressure on admission. 
I 
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Results 
Study sample 
The 183 persons in our study sample were compared with the 46 persons 
without recorded delay times and no significant differences were found 
regarding sociodemographic factors, past medical history, clinical presentation, 
or outcome measures. 
The background characteristics of the study participants are found in Table 10. 
All subjects were at least 65 years old and 38% were aged 75 years or older. The 
mean age was 78.0 years. Forty-five percent of the sample was female and 14% 
were black. 
Delay time 
Delay time greater than 6 hours was recorded in 80 of the 183 (43.7%) study 
participants. 
Variables Related to Delay Time 
The results of the univariate analysis in which the frequency of 
sociodemographic factors, past medical history, and clinical presentation 
variables were compared between early and late arrival groups is also found in 
Table 10. Age was the only variable tested which was significantly related to 
prolonged delay (pc.005). Four other variables, Killip class, CPK>4 times 
normal, chest pain on admission, and atrial fibrillation on admission were 
marginally related to prolonged delay (pc.10). 
The results of the multivariate analysis of delay time variables are found in 
Table 11. Killip class, older age, lack of visitation by a home care worker, and 
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lower educational level were all independently predictive of prolonged delay 
(p<.05). 
Effect of Delay Time on Prognosis 
Mortality at 30 days was 15.5% for persons who delayed <6 hours and 28.8% 
for persons who delayed >6 hours. This difference is statistically significant 
(p=.03). The difference in 1 year mortality seen in the two arrival groups (35% vs. 
50%) was also significant (p=.04). There was no relationship between delay time 
and several inhospital complications (Table 12). 
A multivariate analysis of 30 day and 1 year mortality in which other 
predictors of mortality after AMI were controlled for showed prolonged delay to 
continue to predict increased mortality. The relative risk for 30 day and 1 year 
mortality for persons who delayed more than 6 hours after AMI was found to be 
2.1 (95% confidence interval 1.14 - 4.37) and 2.4 (95% confidence interval 1.41 - 
4.09) respectively (Tables 13 and 14). 
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Discussion 
A principal finding of this study is that measures of social isolation, cognitive 
function, and functional disability were unable to predict prolonged delay in 
elderly persons with AMI. It was hypothesized that these factors would partly 
explain why delay time is increased in older persons. One measure of poor 
functional status, home visitation by a health care worker, was significantly 
related to delay time in a multivariate analysis. However, these persons were 
actually less likely to exhibit prolonged delay than the rest of the study sample. 
The reasons for this are unclear but may reflect a closer surveillance of the health 
status of these persons and prompt encouragement to seek medical attention 
when symptoms arise. 
Other variables besides home visitation by a health care worker that were 
found to be independently predictive of prolonged delay in a multivariate 
analysis were lower Killip class, older age (75+), and lower educational level 
(<12 years). Killip class and age have been associated with prolonged delay in 
many previous studies (23,24,25,29,31,34,40,42). Educational level has been 
associated with delay in only one previous study (42). 
A second finding of this study was the association of prolonged delay after 
AMI with increased 30-day and 1-year mortality. This increase in mortality 
persisted even when controlling for usual predictors of mortality after AMI such 
as Killup class, age, type of MI, gender, and systolic blood pressure on 
admission. This finding is somewhat surprising considering that only 3 of 183 
study participants received thrombolytic therapy. In the absence of thrombolytic 
therapy, one must assume that much of the benefit of prompt hospital arrival 
was provided by the earlier or more frequent administration of non-thrombolytic 
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interventions such as nitroglycerin, beta-blockers, and aspirin. To the best of our 
knowledge, this is the first study which has controlled for baseline risk factors 
and still found an association between delay time and mortality in a population 
which rarely received thrombolytic therapy. 
The infrequent use of thrombolytics in this study was probably due to a 
combination of factors including the typically low eligibility rates of the elderly, 
reluctance on the part of physicians to use thrombolysis in the elderly, and the 
fact that the study was conducted between 1982 and 1992 and that during much 
of this time period thrombolytic therapy was not yet standard of care. 
The finding that delay time is an independent predictor of mortality after AMI 
in the elderly is important for two reasons. First, it is reassuring to know that 
efforts to encourage prompt hospital arrival when experiencing symptoms of 
AMI likely benefit all elderly persons with AMI, not the minority of elderly who 
are eligible for and receive thrombolytic therapy. Second, our findings may 
explain some of the observed association between older age and increased 
mortality after AMI. Several studies of mortality after AMI have shown that age 
per se remains a strong independent predictor of poor prognosis despite 
extensive efforts to control for baseline characteristics, comorbid illnesses, and 
therapeutic interventions (55-57). However, none of these studies have included 
delay time in their analyses. Perhaps if delay time were included as a baseline 
variable, the strength of the association between age and mortality after AMI 
would diminish. 
A limitation of our study is that it was restricted to persons with AMI who 
presented to the emergency department. It did not include persons who died 
prior to hospital arrival nor persons who survived the myocardial infarction but 
did not come to the hospital despite symptoms or because their myocardial was 
asymptomatic. 
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Authers/Joumal Study years n Confirmed M? Mean age %M %B Delay (mean, median) 
Meischke at aL, 1995 
Annals of Emerg. Med (19) 
1986-1987 2317 no 62 58 2 NA, 2 
23%>6hrs 
Bl et al., 1994 
American J. of Pub. Health (20) 
1988-1990 448 no NA 52 100 14.68,2.66 
YarzebskietaL, 1994 
American Heart Journal (21) 
1986,1988.1990 1279 yes NA 63 NA 4.0,2D 
Heriotetaf., 1993 
J. of Floyal Soc. of Med (22) 
1989-1990 103 no NA NA NA 49%>2 hrs, 21%>4 
Logue et al., 1991 
Annals of Emerg. Med (23) 
1987-1988 400 yes NA NA NA NA.3.5 
Weaver etaL, 1991 
J. of Amer. ColL Cardiology (24) 
1988-1989 3256 yes 56%>65 
28%>75 
66 NA NA, 2D 
Schmidt and Borsch, 1990 
Amer. J. of Cardiology (25) 
1988-1989 126 yes 58 75 NA 5.9,2D 
Clark etal., 1989 
Circulation (26) 
NA 200 no 63 44 74 21 
Ho etal., 1969 
Annals of Emerg. Med (27) 
1986 401 pre 
489 post 
no 63 56 NA NA, 26 
NA, 23 
Leitch, et al., 1999 
Med. J. of Australia (28) 
1987 100 no NR NA NA NA, 2D 
Maynard et aL. 1989 
Amer. J. Cardiology (29) 
1981-88 690 yes NA NA NA 2.1, NA 
Ho etal., 1988 
Circulation (30) 
1986 4102 no NA NA NA 35% <2.21% 24, 
44% >4 hrs 
Rawles and Hakes, 1988 
British Med. Journal (31) 
NR 450 yes 66.6 NA NA 102 
Wielgosz et aL. 1988 
Canadian Med. Assoc. J. (32) 
1986-1987 42 yes NA NA NA 5D.2.0 
Cooper et aL, 1986 
Amer. J. of Cardiology (33) 
1983-1984 111 yes 592 56 100 23,6 
Turi etal., 1986 
Amer. J. of Cardiology (34) 
1978-1983 778 yes NA NA NA NA 
Alonzo, I960 
Medical Care (35) 
1976-1977 1102 no NA 64 14 NA, 2 
Shroederetal, 1978 
Amer. J. of Medicine (36) 
1975 211 no 56 75 NA 7.5,3D 
QiOum et al., 1976 
Archives of Internal Med. (37) 
NA 107 yes NA NA NA NA, 2.75 | 
Simon et aL, 1972 
Amer. J. of Cardiology (38) 
NA 160 yes NA 73 NA NA.2.75 
TjoeetaL, 1972 
Chest (39) 
1970 75 no NA 59 NA NA, NA 
Moss et aL, 1970 
Circulation (40) 
1968-1969 160 yes 61 73 NA NA, 3D 
Hacked et al., 1989 
Amer. J. of Cardiology (41) 
NA 100 no NA 73 NA 10.6,4 
Moss et aL, 1969 
Amer. J. of Cardiology (42) 
1968 64 no NA 73 NA 5, NA 
Table 1. Delay Times Reported in Previous'Studies 
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Authora/Joumal n Older Aga Female Gender Blaok Increased Education Socioeconomic Statue 
Ell etal., 1994 
American J. of Pub. Health (20) 
448 No effect No effect Increased No effect No effect 
Yarzebski etal., 1994 
American Heart Journal (21) 
1279 No effect No effect 
Heriot et a!„ 1993 
J. of Royal Soc. of Med. (22) 
103 No effect 
Logueetal., 1991 
Annals of Emerg. Med. (23} 
400 No effect 
Weaver etal., 1991 
J. of Amer. Coll. Cardiology (24) 
3256 Increased 
Schmidt and Borsch, 1990 
Amer. J. of Cardiology (25} 
126 increased Increased 
Maynard et al., 1989 
Amer. J. Cardiology (29) 
690 Increased No effect 
Schmidt et al„ 1989 
Circulation (43) 
126 Increased No effect Increased 
Rawiesand Hates, 1988 
British Med. Journal (31) 
450 increased 
Wielgosz et al., 1988 
Canadian Med. Assoc. J. (32) 
42 No effect No effect No effect No effect 
Cooper et al., 1986 
Amer. J. of Cardiology (33) 
111 Increased 
Turi etal., 1986 
Amer. J. of Cardiology (34} 
778 Increased increased No effect 
Alonzo. 1980 
Medical Care (35) 
1102 No effect Increased Increased 
Shroeder etal., 1978 
Amer. J. of Medicine (36) 
211 No effect 
Gillum etal., 1976 
Archives of Internal Med. (37) 
107 No effect No effect 
Simon etal., 1972 
Amer. J. of Cardiology (38) 
160 No effect No effect No effect No effect 
Moss etal., 1970 
Circulation (40) 
160 Increased No effect No effect 
Hackett et al., 1969 
Amer. J. of Cardiology (41) 
100 No effect No effect 
Moss etal., 1969 
Amer. J. of Cardiology (42} 
64 Increased Increased Decreased 
Table 2. Reported Effect of Sociodemographic Variables on Delay Time 
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Authors/Joumal n M! Angina chf Diabetes Hypertension Coronary Heart Disease 
ElletaL, 1994 
American J. of Pub. Health (20) 
448 No effect No effect 
Yarzebski etal., 1994 
American Heart Journal ^21) 
1279 Increased No effect Increased No effect 
Logue etal., 1991 
Annals of Emerg. Med. (23) 
400 No effect 
Schmidt and Borsch, 1990 
Amer. J. of Cardiology (25) 
126 No effect No effect No effect Increased 
Leiteh etal., 1989 
MedJ. of Australia (28) 
100 No effect 
Maynard etal., 1989 
Amer. J. Cardiology (29) 
690 No effect 
Rawtes and Haites, 1988 
British Med. Journal (31) 
450 No effect 
Wielgosz et al., 1986 
Canadian Med. Assoc. J. (32) 
42 No effect No effect 
TurietaJ., 1986 
Amer. J. of Cardiology (34) 
778 No effect Increased Increased Increased 
Shroeder etal., 1978 
Amer, J. of Medicine (36) 
211 Increased Increased 
Gillum et al., 1976 
Archives of Internal Med. (37) 
107 No effect 
Simon etal., 1972 
Amer. J. of Cardiology (38) 
160 No effect No effect 
Tjoeetal., 1972 
Chest (39) 
75 No effect 
Moss etal., 1970 
Circulation (40) 
160 No effect Increased No effect Increased Decreased 
Hackettetal., 1969 
Amer. J. of Cardiology (41) 
100 No effect 
Moss etal., 1969 
Amer. J. of Cardiology (42) 
64 No effect No effect No effect No effect No effect 
Table 3. Reported Effect of Past Medical History on Delay Time 
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Authors/Journal n Patient alone Patient at home Onset during day Onset during weekend 
YarzebskietaL, 1994 
American Heart Journal (21) 
1279 Increased No effect No effect No effect 
Schmidt and Borsch, 1990 
Amer. J. of Cardiology (25) 
126 No effect 
Wielgoszetal., 1988 
Canadian Med. Assoc. J. (32) 
42 No effect Decreased 
Turietal., 1986 
Amer. J. of Cardiology (34) 
778 Increased 
Alonzo, 1986 
Soc. Sd. Med. (44) 
1102 Decreased Decreased 
Mossetal., 1970 
Circulation (40) 
160 Decreased 
Hackett et al., 1969 
Amer. J. of Cardiology (41) 
100 Decreased 
Moss etal., 1969 
Amer. J. of Cardiology (42) 
64 Decreased Increased Increased 
Table 4. Reported Effect of Circumstances of AMI on Delay Time 
Authors/Journal n Chest pain Severe chest pain Slowly progressive pain 
Ell etal., 1994 
Amer. J. of Public Health (20) 
448 Decreased 
Schmidt and Borsch, 1990 
Amer. J. of Cardiology (25) 
126 No effect Decreased Increased 
Maynard etal., 1989 
Amer. J. of Cardiology (29) 
690 No effect 
Mossetal., 1970 
Circulation (40) 
160 No effect 
Hackett et al., 1969 
Amer. J. of Cardiology (41) 
100 Decreased 
Table 5. Reported Effect of Symptoms of AMI on Delay Time 
I 

33 
Authors/Jouma! n Hemodynamic Instability Large Infarct Q wave Ml 
Yarzebski et aJ., 1994 
Amer. Heart Journal (21) 
1279 No effect 
Logue et al., 1991 
Annals of Emergency Med. (23) 
400 Decreased 
Schmidt and Borsch, 1990 
Amer. J. of Cardiology (25) 
126 Decreased No effect 
Maynard et al., 1989 
Amer. J. of Cardiology (29) 
690 Decreased 
Leitch et a!., 1989 
Med. J. of Australia (28) 
100 No effect 
Turietal., 1986 
Amer. J. of Cardiology (34) 
778 Decreased 
Table 6. Reported Effect of Severity of AMI on Delay Time 
Authors/Journal n Symptoms psrcsWsd 
as cardiac 
Knowledge ol 
thrombolytlcs 
Knowledge of benefits 
of early treatment 
Exposure to public 
educational campaign 
Heriot eta!., 1993 
J. of Royal Soc. of Med. (22) 
103 Decreased Decreased Decreased 
Btohmeta)., 1992 
American J. of Cardiology (45) 
632 Decreased 
Schmidt and Borscht, 1990 
Amer. J. of Cardiology (25} 
126 No effect No effect No effect 
Clark et al., 1989 
Circulation (26) 
200 Decreased 
HoetaL, 1989 
Annals of Emerg. Med. (27) 
890 No effect 
Miticetal., 1934 
Canadian J. of Pub. Health (46) 
471 Decreased 
Hackettet al., 1969 
Amer. J. of Cardiolgy (41) 
100 Decreased 
Table 7. Reported Effect of Medical Sophistication on Delay Time 
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Authors/Joumal n Self-medication Contacted MD Informed family member 
Ell et al.. 1994 
Amer. J. of Public Health (20) 
448 Increased 
Heriot et al., 1993 
J. of Royal Soc. of Med. (22) 
102 Increased 
Schmidt and Borsch, 1990 
Amer. J. of Cardiology (25) 
126 No effect Increased 
Leitch et al., 1989 
Medical J. of Australia (28) 
100 Increased 
Weilgosz et al., 1988 
Can. Med. Assoc. Journal (32) 
42 Increased 
Alonzo, 1986 
Soc. Sd Med. (44) 
1102 Increased Increased Increased 
Turi et al., 1986 
Amer. J. of Cardiology (34) 
778 Increased 
Schroederetal., 1978 
Amer. J. of Medicine (36) 
211 Increased 
Simon et al., 1972 
Cardiology (38) 
160 Increased 
Hacketetal., 1969 
Amer. J. of Cardiology (41) 
100 Increased 
Table 8. Reported Effect of Patient Actions on Delay Time 
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Author*/Journal n Inckmion erttaria % Thrombolyttes Multivariate analysis 
Caggatal, 1001 
Annals dlntamal Mad. 
1144 pts hocpitaizad in Mcht- 
gan hospital with verified 
Ml but declared ineigWe 
ter thrombotytics 
0 no significant effect of delay time on 
inhospital mortality when controlling for 
age. stroke or bleeding risk, gender, pre¬ 
vious Ml. location of Ml. duration of chest 
pain, chronic angina. HTN, and peak 
creatine kinase level 
LoguaataL, 1981 
Annals at Emorg Med. 
400 consecutive pts * 
midwest teaching 
hospital with vented 
AMI 
18.5 persons arriving in <1.5 hours had 
a significantly increased inhospital 
mortality rate even when controlling for 
age. previous Ml, chronic angina, and 
Killip class 
Maynard at aL. 1988 
Amer. J. Cardiology 
690 pis from 3 Washington 
state thrombolytic trials 
with verified Ml and 
age <75; in 2 studies those 
who delayed >6 hrs were 
excluded and in one study 
those who delayed >12 hrs 
were excluded 
62.6 no significant effect of delay time on 14- 
day or 1-year mortality when controlling 
for pulmonary edema, location of Ml, 
hypotension, and chest pain 
TuriataL, 1966 
Amer. J. of Cardiology 
778 pts wth verified Ml from 
MIUS study who were 
<76 years old and who 
delayed <18 hours 
0 no significant effect of delay time on 
inhospital, 14-day, or 2-year mortality 
when controlling for age. education, 
previous Ml, gender, diabetes, and previous 
OF 
Table 9. Previous Multivariate Analyses of the Effect of Delay Time on Mortality 
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Variable All patients (%) Early arrival group (%) 
(<6 hours) 
Late Arrival Group (%) 
(>6hours) 
P value 
Soaodemographic 
Age 65-74 36.6 45.6 25 0.004 
75+ 63.4 54.4 75 
Black race 14.2 10.7 18.8 0.121 
Female 44.8 41.7 48.8 0.345 
Education >12 years 30 34.3 24.4 0.149 
Married 34.8 37.3 31.6 0.432 
Medical History 
Myocardial infarction 24.6 24.3 25 0.91 
Chronic angina 42 43.3 40.3 0.686 
Hypertension 55.2 50.5 61.3 0.146 
Diabetes mellitus 28.4 30.1 26.3 0.631 
Of1 35 40 36.3 0.749 
Current smoker 16.9 17.5 16.3 0.826 
BMI <23 33 31.4 35.1 0.208 
24-27 35.8 32.4 40.3 
>28 31.3 36.3 24.7 
CVA 13.1 13.6 12.5 0.828 
Clinical Presentation 
Systolic BP T1 36.6 35.9 37.5 0.829 
T2 32.8 33 32.5 
T3 30.6 31.1 30 
Chest pain 83.7 88.1 77.9 0.068 
CPK > 4X normal 28.3 34 21.3 0.059 
Conduction disorder 13.1 12.6 13.8 0.822 
Atrial fibrillation 13.7 9.7 18.8 0.077 
Killup class 1 54.1 49.5 5 0.056 
II 14.8 13.6 16.3 
III 27.9 32 22.5 
IV 3.3 4.9 1.3 
Type of Ml - Q wave 27.9 30.1 25 0.641 
norvQ 57.4 54.4 61.3 
undetermined 14.8 15.5 13.8 
Social Isolation 
Social ties - zero 6.6 6 8 6.3 0.621 
one 30 29.1 31.3 
two 30 28.2 32.5 
three+ 33.3 35.9 30 
Lives alone 45.9 44.7 47.5 0.702 
Cognitive Function 
Cognitive function impaired 9.4 7.9 11.3 0.446 
Dementia 4.4 3.8 5 0.714 
Functional ability 
functional disability - zero 7.7 78.6 73.8 0.375 
one 10.9 10.7 11.3 
two 12.6 10.7 1 5 
Previous nursing home 4.9 4.9 5 0.964 
Home care worker visits 11.5 13.6 8.8 0.308 
Table 10. Comparison of the Frequency of Delay Time Variables 
in Early and Late Arrival Groups 

37 
Variable Odds Ratio 95% Confidence Interval Standard Error P value 
Higher Killip class 0.2746 .1138 - .6629 0.4496 0.004 
Home care worker visits 0.1837 .0454 - .7427 0.7127 0.0174 
Older age (75+) 2.4 1.1585 * 4.9701 0.3715 0.0185 
Education >12 years 0.4268 .1876 - .9711 0.4194 0.0423 
CPK > 4X normal 0.3948 .1549 • 1.006 0.4774 0.0516 
Chest pain on admission 0.385 .1367 - 1.084 0.5282 0.0708 
Black race 2.2255 .7902 - 6.268 0.5283 0.1299 
Functional Disability 1.726 .6549 - 4.546 0.4944 0.2695 
Female 1.4752 .6950 - 3.1313 0.384 0.3113 
Atrial fibrillation on admission 1.6366 .5705 - 4.6950 0.5377 0.3596 
Cognitive dysfunction 1.6305 .4787 - 5.5538 0.6253 0.4343 
Systolic BP on admission 0.8498 .5407 - 1.3357 0.2307 0.4807 
Q wave Ml 1.357 .5425 - 3.3946 0.4678 0.514 
Social Ties 0.9427 .6417 - 1,4143 0.2016 0.8099 
Live Alone 0.9178 .4286 - 1.9653 0.3885 0.8252 
Table 11. Multivariate Analysis of Variables Associated with Prolonged Delay 
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Variable All patients (%) Early Arrival Group (%) 
(<6 hours) 
Late Arrival Group (%) 
(>6 hours) 
P value 
Inhospltal chest pain 33.5 35 31.6 0.634 
Inhospital ischemia 16.5 16 17.1 0.845 
Inhospltal relnfarctlon 6.8 4 10.5 0.089 
Inhospltal CHF 20.5 18 23.7 0.345 
30-day mortality 21.3 15.5 28.8 0.03 
1-year mortality 41.5 35 50 0.04 
Table 12. Univariate Analysis of Delay Time and Outcome 
Variable Relative risk 95% Confidence Interval 
Q wave Ml 3.327 1.728-6.405 
Killip class 2.237 1.114-4.374 
Delay > 6 hours 2.096 1.006-4.124 
Older age (75+) 1.054 1.003-1.108 
Female gender 0.584 .294-1.159 
Systolic BP on admission 0.518 .338-.795 
Table 13. Multivariate Analysis of Prolonged Delay and 30-Day Mortality 
Variable Relative risk 95% Confidence Interval 
Killip class 3.136 1.858 - 5.293 
Delay > 6 hours 2.4 1.409 - 4.087 
Q wave Ml 1.605 .817 - 3.155 
CPK > 4X normal 1.33 .702 - 2.520 
Older age (75+) 1.029 .992 - 1.068 
Female gender 0.613 .368 - 1.024 
Systolic BP on admission 0.561 .702 - 2.520 
Table 14. Multivariate Analysis of Prolonged Delay and 1-Year Mortality 
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